CAS: 912628-39-8
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Monoclonal IgG System Suitability REF: 45-1445550CAS: 912628-39-8 | - - - | 1,655.00 € | Thu 12 Dec 24 | |
USP mAb 003, Monoclonal IgG1 REF: 45-1445595CAS: 912628-39-8 | - - - | 1,505.00 € | Thu 12 Dec 24 | |
Drozitumab REF: TM-T76802CAS: 912628-39-8 | 95% - 95% | To inquire | Mon 16 Dec 24 | |
Drozitumab REF: 3D-CLA1252CAS: 912628-39-8 | - - - | To inquire | Fri 27 Dec 24 |
Monoclonal IgG System Suitability
CAS:912628-39-8
Immunological products, mixed, not put up in measured doses or in forms or packings for …
Formula:
C6334H9792N1700O2000S42
Color and Shape:
White Lyophilized Cake
Molecular weight:
143014.50475
Estimated delivery in United States, on Thursday 12 Dec 2024
USP mAb 003, Monoclonal IgG1
CAS:912628-39-8
Immunological products, unmixed, not put up in measured doses or in forms or packings for …
Color and Shape:
Colorless Clear Liquid
Molecular weight:
203.09061
Estimated delivery in United States, on Thursday 12 Dec 2024
Drozitumab
CAS:912628-39-8
Drozitumab (PRO 95780) is a human agonist monoclonal antibody targeting DR5 with antitumor effects on …
Purity:
95% - 95%
Color and Shape:
Liquid
Molecular weight:
143.1 (kDa)
Ref: TM-T76802
5mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
Ref: 3D-CLA1252
Undefined size | To inquire |
Estimated delivery in United States, on Friday 27 Dec 2024